SANUWAVE Health, Inc.

For the period ended Dec 31, 2025. Filed Mar 26, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 26, 2026

SNWV$1.88+1.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets as of December 31, 202 and

CONSOLIDATED BALANCE SHEETS

December 31, 2025 and 2024

(In thousands, except share data) · 2025 · 2024 (As Restated)
ASSETS
Current Assets:
Cash and cash equivalents	$11,959	$10,237
Accounts receivable, net of allowance of $1,265 and $1,147, respectively	5,422	3,329
Inventory	5,934	4,149
Prepaid expenses and other current assets	1,312	682
Total Current Assets	24,627	18,397
Non-Current Assets:
Property and equipment, net	1,972	303
Right of use assets, net	390	429
Intangible assets, net	3,026	3,730
Goodwill	7,260	7,260
Secured revolving credit facility debt issuance costs, net	68	-
Total Non-Current Assets	12,716	11,722
Total Assets	$37,343	$30,119
LIABILITIES
Current Liabilities:
Current portion of secured term loan	$5,638	$	-
Senior secured debt	-	25,305
Accounts payable	3,251	3,728
Accrued expenses	8,382	7,756
Warrant liability	-	8,107
Current portion of operating lease liabilities	157	126
Current portion of finance lease liabilities	-	175
Current portion of contract liabilities	388	193
Accrued interest	24	-
Other	7	33
Total Current Liabilities	17,847	45,423
Non-Current Liabilities:
Secured term loan, net of current portion and debt issuance costs	15,667	-
Secured revolving credit facility	655	-
Operating lease liabilities, less current portion	854	125
Finance lease liabilities, less current portion	-	66
Contract liabilities, less current portion	701	300
Total Non-Current Liabilities	17,877	491
Total Liabilities	35,724	45,914
Commitments and Contingencies (Note 21)
STOCKHOLDERS’ EQUITY (DEFICIT)
Preferred stock, par value $0.001, 5,000,000 shares authorized, 6,175 Series A, 293 Series B, 90 Series C, and 8 Series D designated shares, respectively; no shares issued and outstanding at December 31, 2025 and 2024	-	-
Common stock, par value $0.001, 2,500,000,000 shares authorized, 8,588,876 and 8,543,686 issued and outstanding at December 31, 2025 and 2024, respectively	9	9
Additional paid-in capital	244,285	238,685
Accumulated deficit	(242,685)	(254,499)
Accumulated other comprehensive loss	10	10
Total Stockholders’ Equity (Deficit)	1,619	(15,795)
Total Liabilities and Stockholders’ Equity (Deficit)	$37,343	$30,119

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.